As is customary, FDA stayed its approval of the ANDAs for 30 months once Solvay filed suit.

FORBES: FTC Orders Merged Drug Companies Not to Do "Pay-for-Delay" Settlements

Ultimately, it will be the archival system of record for new drug applications (NDAs), biologics license applications (BLAs), and abbreviated new drug applications (ANDAs) as well.

FORBES: UPDATE:Former FDA Chemist Named in Insider Trading Cases